Your browser doesn't support javascript.
loading
The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions.
Guigay, Joël; Tahara, Makoto; Licitra, Lisa; Keilholz, Ulrich; Friesland, Signe; Witzler, Pauline; Mesía, Ricard.
Afiliação
  • Guigay J; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
  • Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Tokyo, Japan.
  • Licitra L; Fondazione IRCCS Istituto Nazionale Tumori, University of Milan, Milan, Italy.
  • Keilholz U; Charité Comprehensive Cancer Center, Berlin, Germany.
  • Friesland S; Karolinska Institutet, Stockholm, Sweden.
  • Witzler P; Merck KGaA, Darmstadt, Germany.
  • Mesía R; Medical Oncology Department, Catalan Institute of Oncology, B-ARGO Group-Badalona, Barcelona, Spain.
Front Oncol ; 9: 668, 2019.
Article em En | MEDLINE | ID: mdl-31497530

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França